Calendrier des promotions Moderna
Calendrier avancé
Graphique simple
À propos de l'entreprise
Moderna — американская биотехнологическая компания, занимающаяся исследованием и разработкой лекарств на основе исключительно РНК-мессенджера.В основе компании идея с mRNA — мессенджер РНК. Искуственно создается возбудитель вируса и создается препарат, который тренирует иммунную систему. Надо только расшифровать геном вируса, загрузить в комп, и на выходе будет состав вакцины. И так практически с любым вирусом. Проблема с доставкой этого мРНК в клетки человека. У Модерны 21 разработка, 10 проходят клинические испытания и НОЛЬ одобренных препаратов.
Цена ао | 71.1 |
---|---|
P/S | 130.09 |
P/BV | 5.32 |
EV/EBITDA | -11.94 |
EBITDA | -0.5147 |
P/E | 8.53 |
Сайт | http://www.modernatx.com |
Число акций ао | 0.382 млрд |
Выручка | 0.048 |
Див.доход ао | 0 |
ISIN | US60770K1079 |
Валюта | usd |
IPO date | 2018-12-07 |
Sector | Health Care |
Industry | Biotechnology |
Валюта отчета | usd |
Changement de prix par jour: | 0% (43.47) |
---|---|
Changement de prix par semaine: | -16.1% (51.81) |
Changement de prix par mois: | -24.7% (57.73) |
Changement de prix sur 3 mois: | -49.75% (86.51) |
Changement de prix sur six mois: | -67.29% (132.9) |
Changement de prix par an: | -38.82% (71.05) |
Evolution du prix sur 3 ans: | -72.36% (157.3) |
Evolution du prix sur 5 ans: | -37.53% (69.58) |
Evolution des prix depuis le début de l'année: | -54.19% (94.89) |
|
Sous-estimation
|
Efficacité
|
|||||||||||||||||||||||||||||||||||||
Dividendes
|
Devoir
|
Impulsion de croissance
|
Date de transaction | Date de divulgation | Insider | Taper | Prix | Volume | Quantité | Partagez jusqu'à, % | Partager après, % | Document |
---|---|---|---|---|---|---|---|---|---|
09.09.2024 | 10.09.2024 | Klinger Shannon Thyme Chief Legal Officer |
Vente | 73.57 | 40 537 | 551 | 0 | 0 | lien |
15.07.2024 | 16.07.2024 | Hoge Stephen President |
Vente | 121.12 | 1 816 800 | 15000 | 0 | 0 | lien |
17.06.2024 | 18.06.2024 | Hoge Stephen President |
Vente | 138.16 | 2 072 400 | 15000 | 0 | 0 | lien |
11.06.2024 | 11.06.2024 | AFEYAN NOUBAR Director |
Vente | 148.34 | 30 088 100 | 202832 | 0 | -0.05 | lien |
10.06.2024 | 11.06.2024 | Klinger Shannon Thyme Chief Legal Officer |
Vente | 148.09 | 766 810 | 5178 | 0 | 0 | lien |
28.05.2024 | 29.05.2024 | Klinger Shannon Thyme Chief Legal Officer |
Vente | 162.47 | 210 561 | 1296 | 0 | 0 | lien |
22.05.2024 | 24.05.2024 | AFEYAN NOUBAR Director |
Vente | 157.57 | 2 363 550 | 15000 | 0 | 0 | lien |
15.05.2024 | 17.05.2024 | AFEYAN NOUBAR Director |
Vente | 127.32 | 1 909 800 | 15000 | 0 | 0 | lien |
10.05.2024 | 13.05.2024 | Hoge Stephen President |
Vente | 120.96 | 30 845 | 255 | 0 | 0 | lien |
08.05.2024 | 10.05.2024 | AFEYAN NOUBAR Director |
Vente | 121.68 | 1 825 200 | 15000 | 0 | 0 | lien |
01.05.2024 | 03.05.2024 | AFEYAN NOUBAR Director |
Vente | 110.92 | 1 663 800 | 15000 | 0 | 0 | lien |
24.04.2024 | 26.04.2024 | AFEYAN NOUBAR Director |
Vente | 108.32 | 1 624 800 | 15000 | 0 | 0 | lien |
17.04.2024 | 19.04.2024 | AFEYAN NOUBAR Director |
Vente | 103.38 | 1 550 700 | 15000 | 0 | 0 | lien |
15.04.2024 | 16.04.2024 | Hoge Stephen President |
Vente | 105.02 | 1 575 300 | 15000 | 0 | 0 | lien |
10.04.2024 | 12.04.2024 | AFEYAN NOUBAR Director |
Vente | 107.12 | 1 606 800 | 15000 | 0 | 0 | lien |
08.04.2024 | 09.04.2024 | Mock James M Chief Financial Officer |
Vente | 101.93 | 71 861 | 705 | 0 | 0 | lien |
03.04.2024 | 05.04.2024 | AFEYAN NOUBAR Director |
Vente | 101.68 | 1 525 200 | 15000 | 0 | 0 | lien |
27.03.2024 | 29.03.2024 | AFEYAN NOUBAR Director |
Vente | 109.06 | 1 635 900 | 15000 | 0 | 0 | lien |
20.03.2024 | 22.03.2024 | AFEYAN NOUBAR Director |
Vente | 102.39 | 1 535 850 | 15000 | 0 | 0 | lien |
13.03.2024 | 15.03.2024 | AFEYAN NOUBAR Director |
Vente | 108.54 | 1 628 100 | 15000 | 0 | 0 | lien |
20.09.2023 | 22.09.2023 | AFEYAN NOUBAR Director |
Vente | 104.74 | 1 571 100 | 15000 | 0 | 0 | lien |
15.09.2023 | 18.09.2023 | Hoge Stephen President |
Vente | 112.99 | 1 694 850 | 15000 | 0 | 0 | lien |
08.09.2023 | 11.09.2023 | Klinger Shannon Thyme Chief Legal Officer |
Vente | 107.22 | 59 722 | 557 | 0 | 0 | lien |
06.09.2023 | 08.09.2023 | AFEYAN NOUBAR Director |
Vente | 107.61 | 1 614 150 | 15000 | 0 | 0 | lien |
30.08.2023 | 01.09.2023 | AFEYAN NOUBAR Director |
Vente | 115.46 | 1 731 900 | 15000 | 0 | 0 | lien |
23.08.2023 | 25.08.2023 | AFEYAN NOUBAR Director |
Vente | 115.51 | 1 732 650 | 15000 | 0 | 0 | lien |
16.08.2023 | 18.08.2023 | AFEYAN NOUBAR Director |
Vente | 97.56 | 975 600 | 10000 | 0 | 0 | lien |
02.08.2023 | 04.08.2023 | AFEYAN NOUBAR Director |
Vente | 110.99 | 1 664 850 | 15000 | 0 | 0 | lien |
26.07.2023 | 28.07.2023 | AFEYAN NOUBAR Director |
Vente | 120.42 | 1 806 300 | 15000 | 0 | 0 | lien |
19.07.2023 | 21.07.2023 | AFEYAN NOUBAR Director |
Vente | 125.48 | 1 882 200 | 15000 | 0 | 0 | lien |
12.07.2023 | 14.07.2023 | AFEYAN NOUBAR Director |
Vente | 125.81 | 1 887 150 | 15000 | 0 | 0 | lien |
05.07.2023 | 07.07.2023 | AFEYAN NOUBAR Director |
Vente | 124.73 | 1 870 950 | 15000 | 0 | 0 | lien |
28.06.2023 | 30.06.2023 | AFEYAN NOUBAR Director |
Vente | 121.54 | 1 823 100 | 15000 | 0 | 0 | lien |
21.06.2023 | 23.06.2023 | AFEYAN NOUBAR Director |
Vente | 121.95 | 1 829 250 | 15000 | 0 | 0 | lien |
07.06.2023 | 09.06.2023 | AFEYAN NOUBAR Director |
Vente | 125.91 | 1 888 650 | 15000 | 0 | 0 | lien |
31.05.2023 | 02.06.2023 | AFEYAN NOUBAR Director |
Vente | 127.35 | 1 910 250 | 15000 | 0 | 0 | lien |
20.04.2023 | 21.04.2023 | Bancel Stephane Chief Executive Officer |
Vente | 142.99 | 5 719 600 | 40000 | 0 | -0.01 | lien |
20.04.2023 | 21.04.2023 | Bancel Stephane Chief Executive Officer |
Achat | 0.99 | 39 600 | 40000 | 0 | 0.01 | lien |
19.04.2023 | 21.04.2023 | Bancel Stephane Chief Executive Officer |
Vente | 142.88 | 5 715 200 | 40000 | 0 | -0.01 | lien |
19.04.2023 | 21.04.2023 | Bancel Stephane Chief Executive Officer |
Achat | 0.99 | 39 600 | 40000 | 0 | 0.01 | lien |
18.01.2023 | 20.01.2023 | AFEYAN NOUBAR Director |
Vente | 200.2 | 2 002 000 | 10000 | 0 | 0 | lien |
11.01.2023 | 13.01.2023 | AFEYAN NOUBAR Director |
Vente | 188.57 | 1 885 700 | 10000 | 0 | 0 | lien |
21.12.2022 | 23.12.2022 | AFEYAN NOUBAR Director |
Vente | 201.7 | 2 017 000 | 10000 | 0 | 0 | lien |
21.12.2022 | 23.12.2022 | Andres Juan See remarks |
Vente | 201.7 | 403 400 | 2000 | 0 | 0 | lien |
21.12.2022 | 23.12.2022 | Andres Juan See remarks |
Achat | 20.93 | 41 860 | 2000 | 0 | 0 | lien |
23.11.2022 | 25.11.2022 | AFEYAN NOUBAR Director |
Vente | 178.01 | 1 780 100 | 10000 | 0 | 0 | lien |
02.11.2022 | 04.11.2022 | AFEYAN NOUBAR Director |
Vente | 154.2 | 1 542 000 | 10000 | 0 | 0 | lien |
26.10.2022 | 28.10.2022 | AFEYAN NOUBAR Director |
Vente | 137.25 | 1 372 500 | 10000 | 0 | 0 | lien |
19.10.2022 | 21.10.2022 | AFEYAN NOUBAR Director |
Vente | 132.5 | 1 325 000 | 10000 | 0 | 0 | lien |
12.10.2022 | 14.10.2022 | AFEYAN NOUBAR Director |
Vente | 135.36 | 1 353 600 | 10000 | 0 | 0 | lien |
05.10.2022 | 07.10.2022 | AFEYAN NOUBAR Director |
Vente | 122.4 | 1 224 000 | 10000 | 0 | 0 | lien |
28.09.2022 | 30.09.2022 | AFEYAN NOUBAR Director |
Vente | 123.58 | 1 235 800 | 10000 | 0 | 0 | lien |
21.09.2022 | 23.09.2022 | AFEYAN NOUBAR Director |
Vente | 130.37 | 1 303 700 | 10000 | 0 | 0 | lien |
14.09.2022 | 16.09.2022 | AFEYAN NOUBAR Director |
Vente | 134 | 1 340 000 | 10000 | 0 | 0 | lien |
07.09.2022 | 09.09.2022 | AFEYAN NOUBAR Director |
Vente | 129.68 | 1 296 800 | 10000 | 0 | 0 | lien |
31.08.2022 | 02.09.2022 | AFEYAN NOUBAR Director |
Vente | 136.95 | 1 369 500 | 10000 | 0 | 0 | lien |
17.08.2022 | 19.08.2022 | AFEYAN NOUBAR Director |
Vente | 165.24 | 1 652 400 | 10000 | 0 | 0 | lien |
10.08.2022 | 12.08.2022 | AFEYAN NOUBAR Director |
Vente | 174.09 | 1 740 900 | 10000 | 0 | 0 | lien |
10.08.2022 | 11.08.2022 | Hoge Stephen President |
Vente | 173.66 | 42 373 | 244 | 0 | 0 | lien |
09.08.2022 | 11.08.2022 | Hoge Stephen President |
Achat | 171.81 | 89 685 | 522 | 0 | 0 | lien |
03.08.2022 | 05.08.2022 | AFEYAN NOUBAR Director |
Vente | 167.99 | 1 679 900 | 10000 | 0 | 0 | lien |
27.07.2022 | 29.07.2022 | AFEYAN NOUBAR Director |
Vente | 161 | 1 610 000 | 10000 | 0 | 0 | lien |
25.07.2022 | 26.07.2022 | Hoge Stephen President |
Vente | 162.75 | 1 627 500 | 10000 | 0 | 0 | lien |
20.07.2022 | 22.07.2022 | AFEYAN NOUBAR Director |
Vente | 167 | 1 670 000 | 10000 | 0 | 0 | lien |
13.07.2022 | 15.07.2022 | AFEYAN NOUBAR Director |
Vente | 168.88 | 1 688 800 | 10000 | 0 | 0 | lien |
06.07.2022 | 08.07.2022 | AFEYAN NOUBAR Director |
Vente | 154.85 | 1 548 500 | 10000 | 0 | 0 | lien |
29.06.2022 | 01.07.2022 | AFEYAN NOUBAR Director |
Vente | 140.47 | 1 404 700 | 10000 | 0 | 0 | lien |
24.06.2022 | 27.06.2022 | Hoge Stephen President |
Vente | 143.98 | 719 900 | 5000 | 0 | 0 | lien |
24.06.2022 | 27.06.2022 | Hoge Stephen President |
Achat | 10.9 | 54 500 | 5000 | 0 | 0 | lien |
23.06.2022 | 27.06.2022 | Hoge Stephen President |
Vente | 135.96 | 679 800 | 5000 | 0 | 0 | lien |
23.06.2022 | 27.06.2022 | Hoge Stephen President |
Achat | 10.9 | 54 500 | 5000 | 0 | 0 | lien |
22.06.2022 | 24.06.2022 | AFEYAN NOUBAR Director |
Vente | 127.69 | 1 276 900 | 10000 | 0 | 0 | lien |
08.06.2022 | 10.06.2022 | AFEYAN NOUBAR Director |
Vente | 147.47 | 1 474 700 | 10000 | 0 | 0 | lien |
25.05.2022 | 27.05.2022 | AFEYAN NOUBAR Director |
Vente | 130.8 | 1 308 000 | 10000 | 0 | 0 | lien |
18.05.2022 | 20.05.2022 | AFEYAN NOUBAR Director |
Vente | 138.38 | 1 383 800 | 10000 | 0 | 0 | lien |
14.04.2022 | 15.04.2022 | Bancel Stephane Chief Executive Officer |
Vente | 168.59 | 1 685 900 | 10000 | 0 | 0 | lien |
13.04.2022 | 15.04.2022 | Andres Juan See remarks |
Vente | 158.37 | 316 740 | 2000 | 0 | 0 | lien |
13.04.2022 | 15.04.2022 | Andres Juan See remarks |
Achat | 14.22 | 28 440 | 2000 | 0 | 0 | lien |
13.04.2022 | 15.04.2022 | Bancel Stephane Chief Executive Officer |
Vente | 170.26 | 1 532 340 | 9000 | 0 | 0 | lien |
03.02.2022 | 04.02.2022 | Bancel Stephane Chief Executive Officer |
Vente | 165 | 1 650 000 | 10000 | 0 | 0 | lien |
02.02.2022 | 04.02.2022 | Bancel Stephane Chief Executive Officer |
Vente | 170.89 | 1 538 010 | 9000 | 0 | 0 | lien |
24.01.2022 | 25.01.2022 | Hoge Stephen President |
Vente | 150.67 | 3 013 400 | 20000 | 0 | 0 | lien |
24.01.2022 | 25.01.2022 | Hoge Stephen President |
Achat | 5.95 | 119 000 | 20000 | 0 | 0 | lien |
20.01.2022 | 21.01.2022 | Bancel Stephane Chief Executive Officer |
Vente | 175.01 | 1 750 100 | 10000 | 0 | 0 | lien |
19.01.2022 | 21.01.2022 | Bancel Stephane Chief Executive Officer |
Vente | 188.55 | 1 696 950 | 9000 | 0 | 0 | lien |
22.11.2021 | 23.11.2021 | Andres Juan See remarks |
Vente | 268.18 | 4 022 700 | 15000 | 0 | 0 | lien |
22.11.2021 | 23.11.2021 | Andres Juan See remarks |
Achat | 13.55 | 203 250 | 15000 | 0 | 0 | lien |
19.11.2021 | 23.11.2021 | Andres Juan See remarks |
Vente | 265.71 | 1 328 550 | 5000 | 0 | 0 | lien |
19.11.2021 | 23.11.2021 | Andres Juan See remarks |
Achat | 12.21 | 61 050 | 5000 | 0 | 0 | lien |
16.06.2021 | 21.06.2021 | Zaks Tal Zvi Chief Medical Officer |
Vente | 200 | 1 000 000 | 5000 | 0 | 0 | lien |
16.06.2021 | 21.06.2021 | Zaks Tal Zvi Chief Medical Officer |
Achat | 25.93 | 129 650 | 5000 | 0 | 0 | lien |
31.03.2021 | 31.03.2021 | AFEYAN NOUBAR Director |
Vente | 121.07 | 591 790 | 4888 | 0 | 0 | lien |
30.03.2021 | 31.03.2021 | AFEYAN NOUBAR Director |
Vente | 118.97 | 251 359 000 | 2112795 | 0 | -0.64 | lien |
29.03.2021 | 31.03.2021 | AFEYAN NOUBAR Director |
Vente | 124.6 | 203 736 000 | 1635122 | 0 | -0.5 | lien |
23.03.2021 | 25.03.2021 | HENDERSON LORI M. General Counsel and Secretary |
Vente | 145.55 | 960 630 | 6600 | 0 | 0 | lien |
23.03.2021 | 25.03.2021 | HENDERSON LORI M. General Counsel and Secretary |
Achat | 20.93 | 138 138 | 6600 | 0 | 0 | lien |
Établissements | Volume | Partager, % |
---|---|---|
Baillie Gifford and Company | 45654527 | 11.92 |
Vanguard Group Inc | 33907072 | 8.86 |
Blackrock Inc. | 25301692 | 6.61 |
State Street Corporation | 14623723 | 3.82 |
Flagship Pioneering Inc. | 9666038 | 2.52 |
Theleme Partners LLP | 7349456 | 1.92 |
Wellington Management Group, LLP | 7225579 | 1.89 |
Geode Capital Management, LLC | 6549461 | 1.71 |
FMR, LLC | 6393351 | 1.67 |
Goldman Sachs Group Inc | 4551626 | 1.19 |
Superviseur | Titre d'emploi | Paiement | Année de naissance |
---|---|---|---|
Mr. Stephane Bancel | CEO & Director | 4.55M | 1973 (51 année) |
Ms. Lavina Talukdar CFA | Senior VP & Head of Investor Relations | N/A | |
Ms. Shannon Thyme Klinger | Chief Legal Officer & Corporate Secretary | 1.39M | 1971 (53 année) |
Dr. Stephen Hoge M.D. | President | 1.92M | 1977 (47 années) |
Mr. James M. Mock | Chief Financial Officer | 1.4M | 1977 (47 années) |
Dr. Jerh Collins Ph.D. | Chief Technical Operations & Quality Officer | N/A | 1967 (57 années) |
Mr. Brad Miller | Chief Information Officer | N/A | 1974 (50 années) |
Colleen Hussey | Senior Director of Corporate Communications | N/A | |
Ms. Tracey Franklin | Chief Human Resources Officer | N/A | 1981 (43 année) |
Dr. Melanie Ivarsson M.B.A., Ph.D. | Chief Development Officer | N/A |
Adresse: United States, Cambridge, MA , 200 Technology Square - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: http://www.modernatx.com
Site web: http://www.modernatx.com